Arcturus Therapeutics Holdings Inc. SEC filings ARCT
Arcturus Therapeutics Holdings Inc. has 416 filings in SEC EDGAR's recent list, going back to Mar 18, 2019. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Nov 12, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Dec 30, 2022 | — |
| CORRESP | Letter to the SEC | Dec 30, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2022 | — |
| DEL AM | Filing | Dec 27, 2022 | — |
| DEFR14A | Filing | May 12, 2022 | — |
| NT 10-Q | Filing | Aug 10, 2021 | Jun 30, 2021 |
| EFFECT | Filing | Jun 26, 2020 | — |
| CORRESP | Letter to the SEC | Jun 19, 2020 | — |
| EFFECT | Filing | May 21, 2020 | — |
| CORRESP | Letter to the SEC | May 18, 2020 | — |
| UPLOAD | Letter from the SEC | May 15, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 24, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 3, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2019 | — |
| EFFECT | Filing | Jul 29, 2019 | — |
| CORRESP | Letter to the SEC | Jul 25, 2019 | — |
| CT ORDER | Filing | Jul 18, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2019 | — |
| 8-K12B | Filing | Jun 14, 2019 | Jun 12, 2019 |
| EFFECT | Filing | Apr 12, 2019 | — |
| CORRESP | Letter to the SEC | Apr 11, 2019 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1768224
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.